Oracle stock jumps toward $200 as Stargate funding and a busy macro week collide

Oracle stock jumps toward $200 as Stargate funding and a busy macro week collide

NEW YORK, Jan 10, 2026, 06:06 EST — Market closed

Oracle shares jumped 4.7% Friday, ending at $198.52 after trading in a range from $188.91 up to $200.13. Buyers drove the stock close to the $200 threshold, a level many traders watch closely as a “line in the sand.” Volume hit roughly 26.2 million shares.

SB Energy announced late Friday that OpenAI and SoftBank are committing $1 billion to boost data-center and power infrastructure for Stargate, a $500 billion project supported by Oracle. The company plans to develop and run a 1.2-gigawatt OpenAI facility in Milam County, Texas. (Reuters)

Oracle’s story now hinges on whether big AI infrastructure deals can translate into steady cloud revenue—and how quickly. The broader market lent support on Friday: the S&P 500 hit a record closing high following a weaker U.S. jobs report. Investors also kept an eye on an upcoming Supreme Court ruling that might shake up the tariff landscape. “Investors are getting granular and picking the winners and losers,” said Zachary Hill, head of portfolio management at Horizon Investments. (Reuters)

Oracle passed a dividend milestone as well. According to a recent filing, the company declared a quarterly cash dividend of 50 cents per share, payable on Jan. 23 to shareholders recorded by Jan. 9. The ex-dividend date marks the first trading day when new buyers won’t receive the upcoming payment. (SEC)

Investors are zeroed in on Oracle’s guidance and how it’s funding its expansion. The company’s latest quarterly report showed heavy capital spending on data centers, with capex hitting roughly $8.1 billion for the quarter ending Nov. 30. Meanwhile, notes payable and borrowings stood at $108.1 billion. Oracle also shared its cloud revenue growth and earnings goals for the fiscal third quarter. (Nasdaq)

The upside scenario still faces hurdles around execution and funding. Back in December, Oracle warned that sales and profit would fall short of expectations, while flagging a $15 billion jump in spending compared to earlier forecasts—highlighting how fast costs are climbing. Then, days later, the company denied reports of OpenAI-related data-center delays. Spokesperson Michael Egbert told Reuters, “There have been no delays to any sites” needed to meet commitments. (Reuters)

Traders are gearing up for Oracle’s upcoming earnings report, expected around March 9, while keeping a close eye on the Federal Reserve’s policy meeting set for Jan. 27-28 for hints on how rate changes might impact tech stocks. The immediate focus, though, is Tuesday, Jan. 13, when the U.S. Labor Department drops the December consumer price index at 8:30 a.m. ET. (Federal Reserve)

Stock Market Today

  • IBM downgraded to Hold by Wall Street Zen; analysts adjust ratings and targets
    January 11, 2026, 3:24 AM EST. IBM was downgraded to Hold by Wall Street Zen from Buy in a Sunday note. Other brokers moved on IBM: Stifel Nicolaus lifted its price target to $325 and kept a Buy. Weiss Ratings upgraded IBM to Buy. Morgan Stanley trimmed its target to $252 and set Equal Weight. Erste Group Bank upgraded to Buy, and RBC lifted its target to $350 with an Outperform rating. Market participants show a mixed consensus: one Strong Buy, ten Buy, five Hold, and one Sell per MarketBeat, with a Moderate Buy overall and a $301.85 average target. IBM traded near $304.36, above a 50-day line of $303.55 and near a 200-day average of $281.97. The stock's last quarterly results beat on EPS and revenue; next year earnings are seen around $10.78. Norges Bank bought a new stake in the second quarter.
NuScale Power stock pops on BofA upgrade as Meta’s nuclear push lifts the SMR trade
Previous Story

NuScale Power stock pops on BofA upgrade as Meta’s nuclear push lifts the SMR trade

Lam Research stock jumps on Mizuho target hike as chip-tool rally sets up next earnings test
Next Story

Lam Research stock jumps on Mizuho target hike as chip-tool rally sets up next earnings test

Go toTop